Ying Cai is the Director of Clinical Supply Chain at Revolution Medicines, specializing in managing end-to-end supply operations for global clinical trials. With a background in Project Management from UC San Diego, she has a proven record of optimizing production timelines and delivering significant cost savings.
She shows a keen interest in the broader pharmaceutical industry, following major companies like Pfizer and Eli Lilly. Ying is also a proponent of global collaboration in response to public health challenges, as demonstrated by her support for frontline workers during the COVID-19 pandemic.
She once achieved over $2 million in annual cost savings by reducing wastage in clinical trial operations.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.